PILOCARPINE HYDROCHLORIDE

N/A

Manufactured by Advanz Pharma (US) Corp.

7,486 FDA adverse event reports analyzed

Last updated: 2026-04-15

About PILOCARPINE HYDROCHLORIDE

PILOCARPINE HYDROCHLORIDE is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by Advanz Pharma (US) Corp.. The most commonly reported adverse reactions for PILOCARPINE HYDROCHLORIDE include DRUG INEFFECTIVE, HEADACHE, VISION BLURRED, NAUSEA, VISUAL IMPAIRMENT. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for PILOCARPINE HYDROCHLORIDE.

Top Adverse Reactions

DRUG INEFFECTIVE432 reports
HEADACHE404 reports
VISION BLURRED203 reports
NAUSEA200 reports
VISUAL IMPAIRMENT200 reports
PAIN188 reports
FATIGUE178 reports
OFF LABEL USE168 reports
EYE PAIN158 reports
DIZZINESS152 reports
DYSPNOEA140 reports
EYE IRRITATION134 reports
ARTHRALGIA131 reports
FALL124 reports
DIARRHOEA121 reports
COUGH113 reports
MALAISE103 reports
PNEUMONIA97 reports
WEIGHT INCREASED97 reports
VOMITING96 reports
URINARY TRACT INFECTION93 reports
ASTHENIA91 reports
OCULAR HYPERAEMIA91 reports
WEIGHT DECREASED90 reports
BLOOD PRESSURE INCREASED89 reports
RASH81 reports
DRY MOUTH80 reports
CONDITION AGGRAVATED76 reports
PAIN IN EXTREMITY76 reports
PRURITUS75 reports
PYREXIA74 reports
NASOPHARYNGITIS66 reports
HYPERHIDROSIS65 reports
VITREOUS FLOATERS65 reports
GAIT DISTURBANCE61 reports
ANXIETY60 reports
DRY EYE60 reports
MIGRAINE60 reports
HYPOTENSION59 reports
INFUSION RELATED REACTION59 reports
HYPERTENSION57 reports
JOINT SWELLING57 reports
PRODUCT DOSE OMISSION ISSUE57 reports
CHEST PAIN56 reports
MYOCARDIAL INFARCTION55 reports
SJOGREN^S SYNDROME55 reports
ASTHMA54 reports
BACK PAIN54 reports
MUSCULOSKELETAL STIFFNESS54 reports
ABDOMINAL PAIN UPPER53 reports
ABDOMINAL DISCOMFORT52 reports
DECREASED APPETITE52 reports
FEELING ABNORMAL52 reports
VITREOUS DETACHMENT50 reports
MYALGIA49 reports
OEDEMA PERIPHERAL49 reports
SINUSITIS49 reports
RETINAL DETACHMENT48 reports
CARDIAC FAILURE CONGESTIVE47 reports
ERYTHEMA47 reports
HOT FLUSH47 reports
INSOMNIA47 reports
ANAEMIA46 reports
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION46 reports
CHEST DISCOMFORT44 reports
DEPRESSION44 reports
LIMB INJURY44 reports
DRUG HYPERSENSITIVITY43 reports
PRODUCTIVE COUGH43 reports
WOUND42 reports
INFLAMMATION41 reports
BRONCHITIS40 reports
HYPERSENSITIVITY40 reports
RHEUMATOID ARTHRITIS40 reports
DEHYDRATION39 reports
HAEMORRHAGE39 reports
INJECTION SITE PAIN39 reports
ARTHROPATHY38 reports
INFECTION38 reports
DYSPHAGIA37 reports
THERAPEUTIC PRODUCT EFFECT INCOMPLETE37 reports
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS37 reports
COVID 1936 reports
DEATH36 reports
HYPOAESTHESIA36 reports
PHOTOPSIA36 reports
TRANSIENT ISCHAEMIC ATTACK36 reports
CHILLS35 reports
ILLNESS35 reports
OROPHARYNGEAL PAIN35 reports
ARTHRITIS34 reports
BURNING SENSATION34 reports
DISCOMFORT34 reports
CONSTIPATION33 reports
GASTROOESOPHAGEAL REFLUX DISEASE33 reports
HAEMOGLOBIN DECREASED33 reports
OXYGEN SATURATION DECREASED33 reports
PALPITATIONS33 reports
PERIPHERAL SWELLING33 reports
SEPSIS33 reports

Report Outcomes

Out of 3,206 classified reports for PILOCARPINE HYDROCHLORIDE:

Serious 49.8%Non-Serious 50.2%

The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.

Demographics Breakdown

Reports by Sex

Female2,145 (76.6%)
Male654 (23.4%)
Unknown1 (0.0%)

Reports by Age

Age 6754 reports
Age 5753 reports
Age 5853 reports
Age 6553 reports
Age 6252 reports
Age 6852 reports
Age 5450 reports
Age 6950 reports
Age 7049 reports
Age 6147 reports
Age 6447 reports
Age 5546 reports
Age 6046 reports
Age 5345 reports
Age 6345 reports
Age 7245 reports
Age 4642 reports
Age 5941 reports
Age 5239 reports
Age 5038 reports

Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.

Frequently Asked Questions

How many FDA adverse event reports are associated with PILOCARPINE HYDROCHLORIDE?

This profile reflects 7,486 FDA FAERS reports that mention PILOCARPINE HYDROCHLORIDE. Reporting is voluntary and does not prove that the drug caused any listed event.

Which adverse reactions are most often listed for PILOCARPINE HYDROCHLORIDE?

Frequently reported terms in FAERS include DRUG INEFFECTIVE, HEADACHE, VISION BLURRED, NAUSEA, VISUAL IMPAIRMENT, PAIN. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.

Who manufactures PILOCARPINE HYDROCHLORIDE?

Labeling and FAERS entries often list Advanz Pharma (US) Corp. in connection with PILOCARPINE HYDROCHLORIDE. Always verify the specific product and NDC with your pharmacist.

Important Disclaimer: This content is generated by AI analysis of FDA adverse event reports and is provided for informational purposes only. It is not medical advice. Adverse event reports submitted to the FDA do not prove that a medication caused the reported side effect. Always consult your healthcare provider before starting, stopping, or changing any medication. If you experience a serious side effect, contact your doctor or call 911 immediately.